IPO Rewind

Attached is our monthly IPO Rewind report. This report identifies a select group of IPOs or spin-offs that have priced in the last two years, giving them time to digest any initial volatility. Our selected ideas display positive fundamental trends with strong top- and bottom-line consensus estimates, and IPO Rewind provides an efficient way to review these ideas that we believe warrant attention.

O’Neil Health Care Weekly

XLV declined 90 bps last week, falling for a third straight week and breaking below its 50-DMA ($153.25). The next level of support is
the 100-DMA ($149.66) followed by a prior pivot of $148.27. Its RS line continues to rapidly decline, warranting an equal – to –
underweight sector positioning. Despite being short-term oversold, Health Care is lagging with few ideas setup technically to buy.

Market View

The U.S. market is in a Confirmed Uptrend. The S&P 500 and Nasdaq traded lower for most of the week before closing strong on Friday to each end with a slight weekly gain. Support for both indices is at their respective 21-DMA (5,673; 17,840). The distribution day count stands at zero and two, respectively.

Market View

The U.S. market is in a Confirmed Uptrend. Indices continue to consolidate recent gains as the S&P 500 is trading at all-time highs while the Nasdaq is only 3% off its high. The first level of support for both indices is at the 10-DMA (5,696, 17,920) followed by the rising 21-DMA (5,614 ,17,573) . The distribution day count stands at zero and one, respectively.

Market View

The U.S. market has been upgraded to a Confirmed Uptrend from a Rally Attempt. The S&P 500 was up 1.4% for the week, staging a Day 9 follow-through day on Thursday and moving into all-time highs. The Nasdaq rose 1.5% for the week but narrowly missed a follow-through day on Thursday, as volume was a bit lower than the prior day. It is testing the midpoint of a 10-week range (18,018) and remains about 4% off all-time highs. The Nasdaq did pick up a Distribution Day on Friday while the S&P 500 avoided one. Rising 21-DMA support for each index is 2-2.5% below (5,585/17,515).

O’Neil Health Care Weekly

XLV declined 2.1% last week, pulling back from all-time high extended levels. The index is now sitting on 21-DMA ($154) support, with
the 50-DMA ($150) 2.4% lower. Despite the pullback, the RS line is still making higher highs, warranting a continued overweight
sector positioning.